Sunday Briefing | #120

The Georgia Straight: "Ex-UBC prof Carl Hansen now worth more than $4 billion following spectacular AbCellera Biologics IPO"

Welcome to this edition of the Vancouver Tech Journal Sunday Briefing, your bi-weekly roundup of Vancouver innovation stories and insights.

Last week, reporters explored the steep drop in local venture financing; the Vancouver company providing a crucial piece of Pfizer’s COVID-19 vaccine; B.C. tech startups’ french connection; and why insiders are buyin…